Page last updated: 2024-11-05

tranexamic acid and Anti-Phospholipid Antibody Syndrome

tranexamic acid has been researched along with Anti-Phospholipid Antibody Syndrome in 2 studies

Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.

Research Excerpts

ExcerptRelevanceReference
" The clinical problems with anticoagulation in patients with lupus anticoagulant include anticoagulant choice, measurement of adequate anticoagulation, antifibrinolytic usage, protamine dosing and blood product transfusion."1.36Lupus anticoagulant, antiphospholipid syndrome and cardiac surgery. ( Bean, M; Cartwright, BL; Cooper, JO, 2010)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cartwright, BL1
Bean, M1
Cooper, JO1
Martínez Rodríguez, E1
Mato, M1
Otero, J1
Ferri, JR1
Gonzálvez, A1
Torres, LM1

Other Studies

2 other studies available for tranexamic acid and Anti-Phospholipid Antibody Syndrome

ArticleYear
Lupus anticoagulant, antiphospholipid syndrome and cardiac surgery.
    Anaesthesia and intensive care, 2010, Volume: 38, Issue:2

    Topics: Aged; Antiphospholipid Syndrome; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Heparin; Human

2010
[Hemostatic drugs in a patient with antiphospholipid syndrome and clinically significant perioperative bleeding].
    Revista espanola de anestesiologia y reanimacion, 2006, Volume: 53, Issue:3

    Topics: Adult; Aminocaproic Acid; Antiphospholipid Syndrome; Aprotinin; Blood Coagulation Tests; Blood Loss,

2006